Swarnroop, a key pharmaceutical company based in Maharashtra, is currently involved in the synthesis of crucial Active Pharmaceutical Ingredients (APIs), notably the API identified as 188062-50-2. This initiative is particularly aligned with essential AIDS studies, supporting worldwide endeavors to address the pandemic. Their state-of-the-art facil